Catalyst
Slingshot members are tracking this event:
Bellicum Pharmaceuticals Announces BPX-501 Clinical Data Updates; EBMT oral presentations highlight encouraging preliminary outcomes from ongoing BP-004 clinical study in children with genetic diseases and cancers
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLCM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 05, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bpx-501
